Literature DB >> 6396516

Impairment of hepatic cytochrome P-450-dependent monooxygenases by the malaria parasite Plasmodium berghei.

A P Alvares, T H Ueng, L W Scheibel, M R Hollingdale.   

Abstract

The effect of Plasmodium berghei infection on hepatic monooxygenase activities and cytochrome P-450 contents was investigated in mice. NIH/NMRI or A/J mice infected with active P. berghei showed 30-40% decreases in hepatic cytochrome P-450 contents and the ability to metabolize the test substrates, ethylmorphine and benzo(a)pyrene. These decreases were observed during the erythrocytic stage of the infection, but not during the initial exoerythrocytic stage, or after heat-inactivated sporozoites were injected. These results strongly suggest that malaria infections may significantly impair the capacity of the liver to metabolize drugs, carcinogens, and other foreign compounds.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6396516     DOI: 10.1016/0166-6851(84)90119-1

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  4 in total

Review 1.  Pharmacokinetics of artemisinin-type compounds.

Authors:  V Navaratnam; S M Mansor; N W Sit; J Grace; Q Li; P Olliaro
Journal:  Clin Pharmacokinet       Date:  2000-10       Impact factor: 6.447

2.  Up- and down-modulation of liver cytochrome P450 activities and associated events in two murine malaria models.

Authors:  Ana Cecilia A X De-Oliveira; Renato S Carvalho; Flavio H M Paixão; Hellen S Tavares; Luciana S Gueiros; Carolina M Siqueira; Francisco J R Paumgartten
Journal:  Malar J       Date:  2010-03-22       Impact factor: 2.979

3.  Interactions among primaquine, malaria infection and other antimalarials in Thai subjects.

Authors:  G Edwards; C S McGrath; S A Ward; W Supanaranond; S Pukrittayakamee; T M Davis; N J White
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

4.  Effects of Plasmodium berghei infection on cytochromes P-450 2E1 and 3A2.

Authors:  K Uhl; J M Grace; D A Kocisko; B T Jennings; A L Mitchell; T G Brewer
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1999 Apr-Jun       Impact factor: 2.569

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.